Valuation (48%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -3.55 | 34.26 |
| PEG Ratio (TTM) | -5.09 | 3.78 |
| P/S Ratio (TTM) | 0.32 | 3.00 |
| P/B Ratio (TTM) | 2.08 | 6.87 |
| P/FCF Ratio (TTM) | 8.20 | 33.52 |
| Price to 5YR AVG Earnings Ratio | -29.76 | 80.95 |
| Price to 5YR AVG FCF Ratio | 23.36 | 603.52 |
Profitability (5%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -16.54% | 8.29% |
| ROE (TTM) | -55.67% | 18.99% |
| Net Profit Margin (TTM) | -9.20% | 7.95% |
| ROIC 5YR AVG | 6.34% | 28.94% |
Growth (62%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 33.31% | 22.81% | -181.58% |
| Revenue | 6.27% | 3.23% | 0.87% |
| Net Income | 34.02% | 23.47% | -174.52% |
| Cash Flow | 177.15% | -58.17% | 56.90% |
Health (37%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.64 | 1.24 |
| Quick Ratio (TTM) | 0.41 | 1.02 |
| D/E Ratio (TTM) | 1.28 | 0.33 |
| Interest Coverage (TTM) | -1.98 | 9.26 |
| Piotroski F-Score | 3 | 7 |
| Altman Z-Score | 2.60 | 4.83 |
| LTL to 5YR AVG FCF | 11.78 | 42.20 |
| Shares Outstanding Growth 5YR AVG | -0.36% | 8.05% |